Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Feb 12, 2015

5262_dirs_2015-02-12_287a94c5-32fd-469e-960f-11048260b947.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8095E

GlaxoSmithKline PLC

12 February 2015

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of an Executive Director's connected person, in the American Depositary Shares (ADS) of GlaxoSmithKline plc as a result of an award made under the GlaxoSmithKline 2009 Performance Share Plan (Performance Share Plan) on 11February 2015 as follows:

Executive Director Name of Connected Person ADS
Dr M Slaoui Mrs K Slaoui 2,030

The Performance Share Plan award was based on an ADS price of US$46.21 (the closing price quoted on the New York Stock Exchange on 11 February 2015). Vesting of the award is subject to meeting performance criteria over a three year period.

The Company and the above named person were advised of these transactions on 12 February 2015.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

VA Whyte

Company Secretary

12 February 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSVLLFFELFLBBB